Bristol Myers Squibb

Bristol Myers Squibb At Bristol Myers Squibb, we work every day to transform patients’ lives through science.

Our commitment to patients is personal.  Now in our 15th year supporting the Blood Cancer United's (formerly The Leukemi...
08/29/2025

Our commitment to patients is personal.

Now in our 15th year supporting the Blood Cancer United's (formerly The Leukemia & Lymphoma Society) Light The Night, we are honored to share the powerful stories of four colleagues whose lives have been personally touched by blood cancer: Jozelle, Mike, Megan and Lexie.

Read their inspiring stories to learn why they choose to walk. https://bit.ly/4mQ5UBS

07/07/2025

In the second episode of our Trials to Transformation series, EVP, General Counsel and Chief Policy Officer Cari Gallman, shares how she transformed challenges into strength.

Watch the latest episode to learn more. https://bit.ly/44tgNSn

We are excited to share important news that will help more patients access  .  The U.S. Food and Drug Administration has...
07/02/2025

We are excited to share important news that will help more patients access .

The U.S. Food and Drug Administration has approved label updates for our therapies, which include the removal of REMS programs and streamlining patient monitoring requirements.

These changes reflect growing confidence in the safety of these therapies and are significant steps toward easing logistical burdens for patients and care partners.

Our unwavering commitment is to break down barriers and expand equitable access to cell therapy, so more eligible patients can benefit from these innovative treatments. https://bit.ly/3IoWLAY

06/30/2025

When life takes an unexpected turn, it can leave a person speechless.

Yet Cari Gallman, EVP, General Counsel and Chief Policy Officer, is raising her voice and sharing her story of how a diagnosis and journey shifted her priorities and perspectives.

In the latest Trials to Transformation with Chris Boerner, Cari opens up about the resilience her journey demanded and the lessons it’s taught her. https://bit.ly/46ojqHF

Living with myasthenia gravis (MG) can be a daily challenge, with fluctuating and unpredictable symptoms. For patients a...
06/26/2025

Living with myasthenia gravis (MG) can be a daily challenge, with fluctuating and unpredictable symptoms. For patients and care partners, the disease journey can feel overwhelming.

That’s why we’re continuing to drive innovative research in to explore potential new treatment options for those living with chronic autoimmune diseases like MG.

This , learn about the impact of autoimmune diseases, like MG, and the need for continued research. https://bit.ly/3TLU8vq

06/23/2025

Cari Gallman, EVP, General Counsel and Chief Policy Officer, shares how getting let go from a job became a turning point in her career in the latest episode of Trials to Transformation with our CEO Chris Boerner. Watch to learn more. https://bit.ly/4ldFhWs

We ride for patients, including our loved ones. This year, over 300 colleagues in 33 countries will bicycle nearly 6,000...
06/18/2025

We ride for patients, including our loved ones. This year, over 300 colleagues in 33 countries will bicycle nearly 6,000 miles across Europe, the United States, Japan and Latin America to raise money for cancer research in our annual ride. Learn more about their epic journey to support patients with cancer: https://bit.ly/4kWAQQ7

Learn more about our clinical trials currently recruiting patients living with rheumatologic conditions like Sjogren’s d...
06/12/2025

Learn more about our clinical trials currently recruiting patients living with rheumatologic conditions like Sjogren’s disease, systemic lupus erythematosus, systemic sclerosis and idiopathic inflammatory myopathies. https://bit.ly/4jNhICW

06/05/2025

Advocacy is a powerful way we ensure patients and their communities are always at the center of our work. At , our patient advocacy team came together to share perspectives and advance meaningful conversations about patient-focused care.

Take a look inside this important event and meet the people who make patient voices heard.

05/30/2025

is a complex puzzle – and we’re committed to understanding how the pieces come together.

For more than 20 years, we have been advancing this mission – treating more than 11,000 patients and building a nationwide network – to help more people benefit from this innovative treatment.

Discover how we’re expanding access to cell therapy to reach as many eligible patients as possible. https://bit.ly/4jv1pu1

05/24/2025

On and every day, we are committed to addressing the needs of people living with schizophrenia, including changing the narrative.

There is a persistent stigma that exists around mental health and neuropsychiatric conditions like schizophrenia.

Learn more about schizophrenia: https://bit.ly/431DqxP

05/14/2025

Schizophrenia is not a one-size-fits-all condition, impacting how a person thinks, feels and behaves.

Often, people have ideas or assumptions about schizophrenia that aren’t true. During , help break the stigma with some simple facts.

Learn more about schizophrenia: https://bit.ly/3ETrQM2

Address

Route 206 & Province Line Road
Princeton, NJ
08543

Alerts

Be the first to know and let us send you an email when Bristol Myers Squibb posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram